One of the prominent members of BET proteins, Brd4, has been implicated in multiple cancers including neuroblastoma, oral, breast, lung, and colon malignancies through ET-mediated protein–protein interactions [38,175]. This evidence concerns the gene BRD4 and neuroblastoma.